Braftm2Mmcm
Targeted Allele Detail
|
Symbol: |
Braftm2Mmcm |
Name: |
Braf transforming gene; targeted mutation 2, Martin McMahon |
MGI ID: |
MGI:7448917 |
Synonyms: |
BrafFA |
Gene: |
Braf Location: Chr6:39580171-39702397 bp, - strand Genetic Position: Chr6, 18.43 cM
|
Alliance: |
Braftm2Mmcm page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:225607
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129/SvEv
|
|
Allele Type: |
|
Targeted (Conditional ready, Humanized sequence, No functional change) |
Mutation: |
|
Insertion
|
|
|
Mutation details: A targeting vector was designed to insert a FRT site and the human BRAF cDNA covering exons 15-18 into intron 14, along with a PGK-neo STOP cassette and a second FRT site. A modified exon 15 was engineered into the vector to encode Braf with a valine to glutamate substitution at amino acid 600 (p.V600E) and a silent XbaI restriction site.
(J:225607)
|
|
|
|
Original: |
J:225607 Shai A, et al., TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis. Cancer Res. 2015 Aug 1;75(15):3167-80 |
All: |
2 reference(s) |
|